Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: A pilot study

European Journal of Clinical Nutrition

Volumn 58, Issue 1, 2004, Pages 173-179

  Campbell, M J ^a   Woodside, J V ^b   Honour, J W ^c   Morton, M S ^d   Leathem, A J C ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antioxidants; Breast cancer; Cardiovascular disease; Insulin like growth factor; Isoflavones; Lipids

Indexed keywords

ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BIOCHANIN A; CHOLESTEROL; CREATININE; DAIDZEIN; EQUOL; FORMONONETIN; GENISTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LIPID; MALONALDEHYDE; ORAL CONTRACEPTIVE AGENT; PLACEBO; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DRUG EXCRETION; DRUG MECHANISM; FEMALE; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORMAL HUMAN; PILOT STUDY; POSTMENOPAUSE; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RED CLOVER; STATISTICAL ANALYSIS; VOLUNTEER;

ADULT; AGED; CHOLESTEROL, HDL; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; ISOFLAVONES; MIDDLE AGED; PILOT PROJECTS; POSTMENOPAUSE; PREMENOPAUSE; SOMATOMEDINS; TRIFOLIUM;

TRIFOLIUM; TRIFOLIUM PRATENSE;

EID: 0742289631     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601764     Document Type: Article

References (35)

1. Anderson JJB, Anthony M, Messina M & Garner SC (1999): Effects of phyto-estrogens on tissues. Nutr. Res. Rev. 12, 75-116.
2. Anderson JW, Johnstone BM & Cook-Newell ME (1995): Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 332, 276-282.
3. Aukema HM, Housini I (2001): Dietary soy protein effects on disease and IGF-1 in male and female Han:SPRD-cy rats. Kidney Int. 59, 52-61.
4. Bingham SA, Atkinson C, Liggins J, Bluck L & Coward A (1998): Phyto-estrogens: where are we now? Br. J. Nutr. 79, 393-406.
5. Campbell MJ, Woodside JV, Secker-Walker J, Titcomb A & Leathem AJC (2001): IGF status is altered by Tamoxifen in breast cancer patients. Mol. Pathol. 54, 307-310.
6. Clemmons DR & Underwood LE (1991): Nutritional regulation of IGF-1 and IGF binding proteins. Ann. Rev. Nutr. 11, 393-412.
7. Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML & Moreton T (2001): The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 8, 259-265.
8. Costa RL & Summa MA (2000): Soy protein in the management of hyperlipidemia. Ann. Pharmacother 34, 931-935.
9. Craft NE, Wise SA & Soares JH (1992): Optimisation of an isocratic high performance liquid chromatography separation of carotenoids. J. Chromatogr. 589, 171-176.
10. Hankinson SE, Willett WC, Colditz GA et al (1998): Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351, 1393-1396.
11. Helle SI, Anker G, Meadows KA et al (1998): Alterations in the insulin-like growth factor system during the menstrual cycle in normal women. Maturitas 28, 259-265.
12. Hodgson JM, Puddey IB, Croft KD, Mori TA, Rivera J & Beilin LJ (1999): Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure. Atherosclerosis 145, 167-172.
13. Howes JB, Sullivan D, Lai N et al (2000): The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of postmenopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152, 143-147.
14. Hsu C-S, Shen WW, Hsueh Y-M & Yeh S-L (2001): Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J. Reprod. Med. 46, 221-226.
15. Jenkins DJA, Kendall CWC, Vidgen E et al (2000): Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. Metabolism 49, 1496-1500.
16. Juul A, Anker G, Pederson AT et al (1997): Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. Hum. Reprod. 12, 2123-2128.
17. Kapiotis S, Hermann M, Held I, Seelos C, Ehringer H & Gmeiner BMK (1997): Genistein, the dietary derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage from atherogenic LDL. Arterioscler. Thromb. Vasc. Biol. 17, 2868-2874.
18. Khalil DA, Lucas EA, Juma S, Smith BJ, Payton ME & Arjmandi BH (2002): Soy protein supplementation increases insulin-like growth factor-1 in young and old men but does not affect markers of bone metabolism. J. Nutr. 132, 2605-2608.
19. Knight DC, Howes JB & Eden JA (1999): The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 2, 79-84.
20. Lissin LW & Cooke JP (2000): Phytestrogens and cardiovascular health. J. Am. Coll. Cardiol. 35, 1403-1410.
21. McKeown NM, Day NE, Welch AA et al (2001): Use of biological markers to validate self-reported dietary intake in a random sample of the European Prospective Investigation into Cancer United Kingdom Norfolk cohort. Am. J. Clin. Nutr. 74, 188-196.
22. Merz-Demlow BE, Duncan AM, Wangen KE et al (2000): Soy isoflavones improve plasma lipids in normocholesterolemic premenopausal women. Am. J. Clin. Nutr. 71, 1462-1469.
23. Morton MS, Wilcox G, Wahlqvist ML & Griffiths K (1994): Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J. Endocrinol. 142, 252-259.
24. Nestel PJ, Pomeroy S, Kay S et al (1999): Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J. Clin. Endocrinol. Metab. 84, 895-898.
25. Pollak M, Costantino J, Polychronakos C et al (1990): Effect of tamoxifen on serum insulin like growth factor-1 levels in stage I breast cancer patients. J. Natl. Cancer. Inst. 82, 1693-1697.
26. Potter SM (1995): Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J. Nutr. 125, S606-S611.
27. Samman S, Lyons Wall PM, Chan GSM, Smith SJ & Petocz P (1999): The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 147, 277-283.
28. Simons LA, von Konigsmark M, Simons J & Celermajer DS (2000): Phytestrogens do not influence lipoprotein levels or endothelial function in healthy postmenopausal women. Am. J. Cardiol. 85, 1297-1301.
29. Takatsuka N, Nagata C, Kurisu Y, Inaba S, Kawakami N & Shimizu H (2000): Hypocholesterolemic effect of soy milk supplementation with usual diet in premenopausal normolipidemic Japanese women. Prev. Med. 31, 308-314.
30. This P, de al Rochefordiere A, Clough K, Fourquet A & Magfelenat H (2001): Phytestrogens after breast cancer. End Relat. Cancer 8, 129-134.
31. Tikkanen MJ, Wahala K, Ojala S, Vihma V & Adlercreutz H (1998): Effect of soybean phytestrogen intake on low density lipoprotein oxidation resistance. Pro. Natl. Acad. Sci. USA 95, 3106-3110.
32. Vuillemier JP & Keck E (1989): Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. J. Micronut. Anal. 5, 25-34.
33. Wangen KE, Duncan AM, Merz-Demlow BE et al (2000): Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J. Clin. Endocrinol. Metab. 85, 3043-3048.
34. 2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 72, 395-400.
35. Young IS & Trimble ER (1991): Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann. Clin. Biochem. 28, 504-508.